Literature DB >> 20158155

Structure-activity relationships of aromadendranes in uterus-relaxant activity.

Nury Pérez-Hernández1, Hector Ponce-Monter, Mario I Ortiz, Raquel Cariño-Cortés, Pedro Joseph-Nathan.   

Abstract

Aromadendranes belong to a class of sesquiterpenes present in higher plant essential oils and marine animals. Although the biological activities include antifungal, antibacterial, antiviral, plant growth regulatory, antifeedant, repellent and cytotoxic, there is only one precedent for spasmolytic effects. In a previous report we have shown that the aromadendrene molecule known as spathulenol, isolated from Lepechinia caulescens, efficiently relaxes rat uterus rings and therefore in the present work we describe structure-activity relationships of thirteen aromadendranes, most of them having the trans-fused perhydroazulene skeleton, with spasmolytic activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20158155     DOI: 10.1515/znc-2009-11-1214

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  3 in total

1.  Vasorelaxant activities and the underlying pharmacological mechanisms of Gynura procumbens Merr. leaf extracts on rat thoracic aorta.

Authors:  Zafar Iqbal; Idris Bello; Mohd Zaini Asmawi; Majed Ahmed Al-Mansoub; Ashfaq Ahmad; Qaiser Jabeen; Yam Mun Fei
Journal:  Inflammopharmacology       Date:  2017-11-28       Impact factor: 4.473

2.  Gold(I) as an artificial cyclase: short stereodivergent syntheses of (-)-epiglobulol and (-)-4β,7α- and (-)-4α,7α-aromadendranediols.

Authors:  Javier Carreras; Madeleine Livendahl; Paul R McGonigal; Antonio M Echavarren
Journal:  Angew Chem Int Ed Engl       Date:  2014-04-01       Impact factor: 15.336

3.  Phytochemical Profile and Antibacterial and Antioxidant Activities of Medicinal Plants Used by Aboriginal People of New South Wales, Australia.

Authors:  Kaisarun Akter; Emma C Barnes; Joseph J Brophy; David Harrington; Yaegl Community Elders; Subramanyam R Vemulpad; Joanne F Jamie
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-02       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.